- No file added yet -
Emerging pharmacotherapy for cancer patients with cognitive dysfunction
Version 3 2024-06-20, 01:21
Version 2 2024-05-30, 15:40
Version 1 2014-10-28, 10:22
journal contribution
posted on 2024-06-20, 01:21 authored by J Davis, FM Ahlberg, Michael BerkMichael Berk, DM Ashley, M KhasrawEmerging pharmacotherapy for cancer patients with cognitive dysfunction
History
Journal
BMC NeurologyVolume
13Article number
ARTN 153Location
EnglandPublisher DOI
Open access
- Yes
ISSN
1471-2377eISSN
1471-2377Language
EnglishPublication classification
C1 Refereed article in a scholarly journalCopyright notice
2013, BioMed CentralIssue
1Publisher
BIOMED CENTRAL LTDPublication URL
Usage metrics
Categories
No categories selectedKeywords
Science & TechnologyLife Sciences & BiomedicineClinical NeurologyNeurosciences & NeurologyCancerCognitive impairmentChemotherapyCognitive dysfunctionPharmacotherapyCROSS-OVER TRIALQUALITY-OF-LIFEBREAST-CANCERDOUBLE-BLINDALZHEIMERS-DISEASECHILDHOOD-CANCERCRANIAL IRRADIATIONRAT-BRAINCHEMOTHERAPYMETHYLPHENIDATE970111 Expanding Knowledge in the Medical and Health Sciences110319 Psychiatry (incl Psychotherapy)111714 Mental Health920410 Mental HealthInnovation in Mental and Physical Health and Clinical TreatmentSchool of MedicineFaculty of Health110999 Neurosciences not elsewhere classified
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC